{"id":"https://openalex.org/W4295225749","doi":"https://doi.org/10.1016/s0090-8258(22)01523-2","title":"A dose-escalation and expansion study of the safety and pharmacokinetics of XB002 in subjects with inoperable locally advanced or metastatic solid tumors (301)","display_name":"A dose-escalation and expansion study of the safety and pharmacokinetics of XB002 in subjects with inoperable locally advanced or metastatic solid tumors (301)","publication_year":2022,"publication_date":"2022-08-01","ids":{"openalex":"https://openalex.org/W4295225749","doi":"https://doi.org/10.1016/s0090-8258(22)01523-2"},"language":"en","primary_location":{"id":"doi:10.1016/s0090-8258(22)01523-2","doi":"https://doi.org/10.1016/s0090-8258(22)01523-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0090-8258(22)01523-2","pdf_url":null,"source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060992997","display_name":"Anthony W. Tolcher","orcid":"https://orcid.org/0000-0002-6322-9721","observed_orcids":["https://orcid.org/0000-0002-6322-9721"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony Tolcher","raw_affiliation_strings":["NEXT Oncology, San Antonio, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NEXT Oncology, San Antonio, TX, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112875869","display_name":"Andrae Vandross","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrae Vandross","raw_affiliation_strings":["NEXT Oncology-Austin, Austin, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NEXT Oncology-Austin, Austin, TX, United States","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Melissa Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melissa Johnson","raw_affiliation_strings":["Sarah Cannon Research Institute / Tennessee Oncology, Nashville, TN, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sarah Cannon Research Institute / Tennessee Oncology, Nashville, TN, United States","institution_ids":["https://openalex.org/I4210100810","https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069669113","display_name":"Haeseong Park","orcid":"https://orcid.org/0000-0002-3430-8463","observed_orcids":["https://orcid.org/0000-0002-3430-8463","https://orcid.org/0000-0003-1487-0042"]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haeseong Park","raw_affiliation_strings":["Washington University in St. Louis, St. Louis, MO, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University in St. Louis, St. Louis, MO, United States","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103600408","display_name":"Christian Scheffold","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christian Scheffold","raw_affiliation_strings":["Exelixis, Inc., Alameda, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exelixis, Inc., Alameda, CA, United States","institution_ids":["https://openalex.org/I152988861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100336882","display_name":"Jing Li","orcid":"https://orcid.org/0000-0002-1232-3056","observed_orcids":["https://orcid.org/0000-0002-1232-3056"]},"institutions":[{"id":"https://openalex.org/I4390039380","display_name":"OU Health Stephenson Cancer Center","ror":"https://ror.org/02bmcqd02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039271","https://openalex.org/I4390039380"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jing Li","raw_affiliation_strings":["OU Health Stephenson Cancer Center, Oklahoma, OK, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OU Health Stephenson Cancer Center, Oklahoma, OK, United States","institution_ids":["https://openalex.org/I4390039380"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113487992","display_name":"Neby Bekele","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039380","display_name":"OU Health Stephenson Cancer Center","ror":"https://ror.org/02bmcqd02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039271","https://openalex.org/I4390039380"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neby Bekele","raw_affiliation_strings":["OU Health Stephenson Cancer Center, Oklahoma, OK, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OU Health Stephenson Cancer Center, Oklahoma, OK, United States","institution_ids":["https://openalex.org/I4390039380"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024641368","display_name":"Shailaja Uttamsingh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039380","display_name":"OU Health Stephenson Cancer Center","ror":"https://ror.org/02bmcqd02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039271","https://openalex.org/I4390039380"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shailaja Uttamsingh","raw_affiliation_strings":["OU Health Stephenson Cancer Center, Oklahoma, OK, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OU Health Stephenson Cancer Center, Oklahoma, OK, United States","institution_ids":["https://openalex.org/I4390039380"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056241510","display_name":"Raffaella Faggioni","orcid":"https://orcid.org/0009-0007-1732-9311","observed_orcids":["https://orcid.org/0009-0007-1732-9311"]},"institutions":[{"id":"https://openalex.org/I152988861","display_name":"Exelixis (United States)","ror":"https://ror.org/01e3jga91","country_code":"US","type":"company","lineage":["https://openalex.org/I152988861"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raffaella Faggioni","raw_affiliation_strings":["Exelixis, Inc., Alameda, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Exelixis, Inc., Alameda, CA, United States","institution_ids":["https://openalex.org/I152988861"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045993166","display_name":"Susanna Varkey Ulahannan","orcid":"https://orcid.org/0000-0002-7234-2283","observed_orcids":["https://orcid.org/0000-0002-7234-2283"]},"institutions":[{"id":"https://openalex.org/I4390039380","display_name":"OU Health Stephenson Cancer Center","ror":"https://ror.org/02bmcqd02","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039271","https://openalex.org/I4390039380"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susanna Ulahannan","raw_affiliation_strings":["OU Health Stephenson Cancer Center, Oklahoma, OK, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OU Health Stephenson Cancer Center, Oklahoma, OK, United States","institution_ids":["https://openalex.org/I4390039380"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4020,"currency":"USD","value_usd":4020},"apc_paid":null,"fwci":0.2844,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.48977969,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":94,"max":96},"biblio":{"volume":"166","issue":null,"first_page":"S158","last_page":"S158"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.483599990606308,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.483599990606308,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.12030000239610672,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.02500000037252903,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9330000281333923},{"id":"https://openalex.org/keywords/tissue-factor","display_name":"tissue factor","score":0.9789999723434448},{"id":"https://openalex.org/keywords/cervical-cancer","display_name":"cervical cancer","score":0.9409999847412109},{"id":"https://openalex.org/keywords/epithelial-ovarian-cancer","display_name":"epithelial ovarian cancer","score":1.0},{"id":"https://openalex.org/keywords/gynecologic-cancer","display_name":"gynecologic cancer","score":0.6349999904632568},{"id":"https://openalex.org/keywords/metastatic-solid-tumors","display_name":"metastatic solid tumors","score":0.7080000042915344},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5400000214576721},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.890999972820282},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8700000047683716},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.8949999809265137},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.8169999718666077},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8050000071525574},{"id":"https://openalex.org/keywords/platinum-resistance","display_name":"platinum resistance","score":0.47200000286102295}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9266266822814941},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6125335097312927},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5846998691558838},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5399167537689209},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4993095397949219},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.4964047074317932},{"id":"https://openalex.org/C2778220009","wikidata":"https://www.wikidata.org/wiki/Q160105","display_name":"Cervical cancer","level":3,"score":0.4821845591068268},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.4686756730079651},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.4562062919139862},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.4316110908985138},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.43036243319511414},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4200045168399811},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.35576725006103516},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.35456860065460205},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3081282377243042},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.27720579504966736},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.22526824474334717},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.145290344953537}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0090-8258(22)01523-2","doi":"https://doi.org/10.1016/s0090-8258(22)01523-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0090-8258(22)01523-2","pdf_url":null,"source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282925038","https://openalex.org/W4403250603","https://openalex.org/W4389280759","https://openalex.org/W4396587369","https://openalex.org/W4307908217","https://openalex.org/W4391091092","https://openalex.org/W4392797250","https://openalex.org/W4404044296","https://openalex.org/W4399738428","https://openalex.org/W7155393812"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":2}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-09-12T00:00:00"}